Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001144204-18-064722
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-14 18:17:56
Reporting Period:
2018-12-14
Accepted Time:
2018-12-14 18:17:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1481512 Ra Pharmaceuticals Inc. RARX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp C/o Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
Yes No Yes No
1346824 Ra Capital Management, Llc 20 Park Plaza, Suite 1200
Boston MA 02116
Yes No Yes No
1384859 Peter Kolchinsky C/o Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-12 1,006,452 $15.50 4,858,260 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. These securities include 836,666 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 169,786shares held in an account owned by a separately managed account (the "Account").
  2. Represents 3,971,750 shares of Common Stock held by the Fund and 886,510 shares of Common Stock held in the Account.
  3. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Dr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii) and disclaim any obligation to file reports under Section 16 other than as directors by deputization. The Adviser and Dr. Kolchinsky have no pecuniary interest in the reported securities held in the Account and disclaim: (A) beneficial ownership thereof for purposes of Rule 16a-1(a)(2) and (B) beneficial ownership of securities held by the Fund, for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.